Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivo.
S. A. Saenz, A. Local, T. Carr, A. Shakya, S. Koul, H. Hu, L. Chourb, J. Stedman, J. Malley, L. A. DAgostino, V. Shanmugasundaram, J. Malona, C. E. Schwartz, L. Beebe, M. Clements, , J. M. Ellis
The paper develops three RORγt inhibitors that reduce Th17 differentiation and inflammation in vivo and inhibit tumor growth in PDAC organoids.
bioRxiv · Feb 19, 2021 · PreprintImmunology